AnnouncementsKilitch Drugs: Outcome of AGM
100% of moneycontrol users recommend buying Kilitch Drugs.
What's your call on Kilitch Drugs today?
Read 4 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3535.00||-0.89||3581.70||2250.00||60,224.32|
|Sep' 14||Jun' 14||Mar' 14||Dec' 13|
|No Mutual Funds Holding the share|
DCB Bank Recommended on Aug 19th 2014
Recommended price 81.00 | Peak from reco 107.05 31.51%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Kilitch Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 40.89 crore.The company has reported a standalone sales of Rs 6.04 crore and a Net Profit of Rs 1.33 crore for the quarter ended Sep 2014.
The company management includes Mukund P Mehta - Managing Director, Paresh P Mehta - Joint Managing Director, Nilima Waigankar - Whole Time Director, Bhavin M Mehta - Executive Director, Mukesh Shah - Independent Director, Pankaj Kamdar - Independent Director, Shailesh Chheda - Independent Director, Hemang Engineer - Independent Director, Mira Mehta - Additional Director, Deepu Kesavan Panankattil - Additional Director.
It is listed on the BSE with a BSE Code of 524500 and the NSE with an NSE Code of KILITCH.
Its Registered office is at C-301/2, MIDC, TTC Industrial area,,Pawane Village Thane,Maharashtra - 400705.
Their Registrars are Link Intime India Pvt. Ltd.